Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Katja Weisel

Katja Weisel

MD
University Medical Center Hamburg-Eppendorf

Academic History

Katja Weisel, MD, University Medical Center Hamburg-Eppendorf, is a Medical Specialist in Internal Medicine and Hematology and Oncology.

Speaking on R/R multiple myeloma

Dr Weisel is interested in the treatment of multiple myeloma, particularly relapsed and refractory multiple myeloma. She is currently conducting the study ‘Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk’.

Katja Weisel

Filter Results ▼
Loading... Loading results...

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals